Athira Pharma - Crunchbase Company Profile & Funding

Q: Who invested in Athira Pharma?

Athira Pharma has 34 investors including Kalehua Capital And Commodore Capital.

Q: When was the last funding round for Athira Pharma?

Athira Pharma closed its last funding round on obfuscated from a Post-IPO Equity round.

Q: How much funding has Athira Pharma raised to date?

Athira Pharma has raised obfuscated.

Overview

Athira Pharma

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Athira Pharma

CB Rank

54025

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

Founded

obfuscation

Public

Post-IPO Equity

Seattle, Washington, United States

51-100

athira.com/

Biotechnology

Pharmaceutical

Therapeutics

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Grant

OBF

obfuscation

Key People

Joseph Harding: Chief Scientific Officer
Andrew Gengos: Chief Financial Officer and Chief Business Officer
Past Role: Cyteir Therapeutics, Chief Business Officer

Details

Legal Name

Athira Pharma, Inc.

Also Known As

M3 Biotechnology

Operating Status

Active

Stock Symbol

NASDAQ:ATHA

Company Type

For Profit

Founders

Joseph Harding, Leen Kawas, Lewis Rumpler

About the Company

Athira Pharma is a clinical-stage drug development company striving to improve human health by advancing bold and innovative therapies with the potential to restore the lives of people impacted by brain disorders.

Athira is derived from the word Athir, the energy that reaches everyone. It captures its mission to develop therapies that can reach

and positively impact everyone.

Phone Number

(206) 221-8112

Contact Email

info@athira.com

Diversity Spotlight

Women Founded

Women Led

Predictions & Insights

Growth Insight

See this Growth Insight

Athira Pharma is

Lorem

to be growing

Top Contributing Factors

Recently Raised Funding

Products & Services

Fosgonimeton

A small molecule drug candidate designed to enhance the neurotrophic hepatocyte growth factor (HGF) system to protect and repair neuronal networks in neurodegenerative diseases.

ATH-1105

An orally available small molecule drug candidate that modulates the neurotrophic HGF system, under investigation for amyotrophic lateral sclerosis (ALS).

Research & Development

Athira Pharma is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Athira Pharma	9	obfuscated obfuscation	Commodore Capital, Perceptive Advisors, TCG Crossover	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Athira Pharma	9	obfuscated obfuscation	Commodore Capital, Perceptive Advisors, TCG Crossover	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Athira Pharma	9	obfuscated obfuscation	Commodore Capital, Perceptive Advisors, TCG Crossover	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Athira Pharma	9	obfuscated obfuscation	Commodore Capital, Perceptive Advisors, TCG Crossover	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Athira Pharma	9	obfuscated obfuscation	Commodore Capital, Perceptive Advisors, TCG Crossover	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Athira Pharma	9	obfuscated obfuscation	Commodore Capital, Perceptive Advisors, TCG Crossover	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Athira Pharma	9	obfuscated obfuscation	Commodore Capital, Perceptive Advisors, TCG Crossover	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Athira Pharma	9	obfuscated obfuscation	Commodore Capital, Perceptive Advisors, TCG Crossover	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Athira Pharma	9	obfuscated obfuscation	Commodore Capital, Perceptive Advisors, TCG Crossover	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Athira Pharma	9	obfuscated obfuscation	Commodore Capital, Perceptive Advisors, TCG Crossover	Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Kalehua Capital	—	Post-IPO Equity - Athira Pharma	—
Kalehua Capital	—	Post-IPO Equity - Athira Pharma	—
Kalehua Capital	—	Post-IPO Equity - Athira Pharma	—
Kalehua Capital	—	Post-IPO Equity - Athira Pharma	—
Kalehua Capital	—	Post-IPO Equity - Athira Pharma	—